• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch Health Companies Inc. Common Stock (TSX:BHC)

    7.130 +0.250 (+3.63%)
    Streaming Delayed Price Updated: 3:35 PM EDT, Mar 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bausch Health Companies Inc. Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
    Via ACCESSWIRE
    News headline image
    Salix Partners with the Colorectal Cancer Alliance on Community Screening Program
    Via ACCESSWIRE
    News headline image
    Bausch Health to Announce First-Quarter 2023 Results on May 4
    Via ACCESSWIRE
    News headline image
    New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
    Via ACCESSWIRE
    News headline image
    Bausch Health Announces Changes to its Board of Directors
    Via ACCESSWIRE
    News headline image
    Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
    Via ACCESSWIRE
    News headline image
    Salix Announces 2023 Gastrointestinal Health Scholars Program
    Via ACCESSWIRE
    News headline image
    Bausch Health Announces Third-Quarter 2022 Results
    Via ACCESSWIRE
    News headline image
    Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
    Via ACCESSWIRE
    News headline image
    Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
    Via ACCESSWIRE
    News headline image
    Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
    Via ACCESSWIRE
    News headline image
    Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
    Via ACCESSWIRE
    News headline image
    Struggling Axsome Stock Could Bounce Back on Drug Trial Success
    Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. 
    Via MarketBeat
    News headline image
    Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge
    Via ACCESSWIRE
    News headline image
    Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference
    Via ACCESSWIRE
    News headline image
    Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
    Via ACCESSWIRE
    News headline image
    Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
    Via ACCESSWIRE
    News headline image
    Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting
    Via ACCESSWIRE
    News headline image
    Bausch Health to Announce Third Quarter 2022 Results on Nov. 3
    Via ACCESSWIRE
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.